Slingshot members are tracking this event:

The FDA has asked Teva to re-analyze blood levels of certain metabolites in a CRL for SD-809 NDA. Teva will submit its response in Q3

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
High Medium Low
Impact on Stocks

Slingshot Insights Explained
Related Projects Image
  • Don’t see a project related to the catalyst you care about?

Related Keywords Sd-809, Deutetrabenazine, Huntington's Disease